tuberculosis (TB) or non-tuberculous mycobacterium (NTM) disease in a UK cohort. Methods An occupational lung disease database (2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017) identified those with an MDT diagnosis of silicosis. Case notes were examined. Results 22 patients were identified. 100% men, mean age 59.1 years (24-83) and mean length of silica exposure of 23.0 years (2-51). 63.6% were current or ex-smokers with a mean pack year history of 27.1 pack years (5-40). Figure 1 shows the relevant occupational history. 5 (22.7%) had an obstructive pattern of spirometry, 5 (22.7%) restrictive, 5 (22.7%) mixed and 7 (31.9%) normal spirometry. Mean FEV1 was 79% predicted (29%-106%) at presentation and FVC 90% predicted (48%-116%). 36.4% of patients had evidence of progressive massive fibrosis on chest radiology at presentation. 18.2% of patients were classified as accelerated silicosis (onset within 10 years of exposure). 19 of 22 (86.4%) silicosis cases identified had actively been screened for TB. 6 of 22 (27.3%) received anti-mycobacterium treatment. 5 of 6 received empirical treatment for TB prior to a diagnosis of silicosis being confirmed, of these 2 later relapsed and had NTM confirmed and treated. The other patient received empirical treatment for TB while awaiting lung transplantation and subsequently died of pulmonary TB. 3 of 6 had NTM grown on at least one occasion. Conclusion This study indicates that rates of TB and NTM in silicosis are relatively high, supporting previously published international data. In addition, this study also highlights the difficulty in diagnosis of TB/NTM in silicosis due to similar clinical and radiological features, frequently leading to patients being treated empirically for TB and high relapse rates. The need for lung transplantation in accelerated disease may also necessitate careful screening for TB/NTM. Abstract P221 Figure 1 Occupations. n=22. 
Background Occupational asthma (OA) is common with c.15% of cases of new or relapsed adult asthma attributed to work. The lifetime cost of a diagnosis is estimated to be £100 million and is largely borne by the patient -who may need to change their job with subsequent loss of earnings -and the State. 1 We sought to understand changes in symptoms over time and the impact of a diagnosis of OA or occupational rhinitis (OR) on patients attending our clinic. Methods Twelve months after diagnosis we sent a postal questionnaire to all patients with occupational rhinitis (OR) or asthma (OA) seen in the Royal Brompton Hospital Occupational Lung Disease. Reminders were sent on one occasion. We present responses from the first 100 completed questionnaires.
Results 73 respondents had OA (response rate 61%) and 27 OR (response rate 39%). 68% of all respondents were male; mean age was 44 years (SD 10.6). Of those with OA, 24 (33%) were bakers and 19 (25%) laboratory animal workers; 29% were in other manual jobs and 13% were in other nonmanual jobs. Occupational groups were similar for those with OR but with a higher proportion of laboratory animal workers (38%) and fewer other manual workers (11%). The majority (83%) of patients were referred to our clinic from Occupational Health services. Most patients, especially those with OR, reported fairly rapid improvement in their condition once removed from exposure although many of those with OA reported consequent difficulties with careers and incomes (table). Overall, almost all patients (OA 87%; OR 93%) claimed that they were 'glad' that their diagnosis had been recognised. Conclusions Prognosis is generally good for patients attending our clinic with most reporting an improvement in their symptoms after diagnosis. Early diagnosis and removal from exposure is known to result in a better prognosis; health care professionals need to have a low threshold for suspecting OA so that patients can be identified early. Introduction and Objectives Occupational asthma (OA) can be prevented by eliminating or at least minimising exposures to the causal agents at work. However, the rapid development of industrial technologies constantly introduces new potential asthmagens at work and therefore up-to-date knowledge of these changes is pivotal to diagnose and prevent new OA cases. The current evidence-based guidance on the prevention and management of OA was commissioned by the British Occupational Health Foundation (BOHRF) in 2010. 1 Our aim was to update these guidelines to help stakeholders reducing the incidence of OA by improved prevention, and the severity of individual cases of disease by earlier identification and better management. Methods We conducted a literature systematic review according to state-of-the-art methods via search of two electronic database (Embase and Medline), using the Ovid interface, from January 2009 to November 2016. Both MeSH and freetext terms were used for combinations of 'work' and 'asthma'. The retrieved references were managed using EndNote software and evaluated blindly by paired reviewers. Critical appraisal of the included articles was performed using the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) scoring system to link evidence-quality evaluations to clinical recommendations. Results From the 2424 references retrieved, 133 met the inclusion criteria (see attached PRISMA flow-chart diagram). Briefly, in terms of occupations, many previously identified were confirmed, such as bakers, and painters, but new ones emerged such as cleaners, suggesting also underlying irritativemediated causal mechanisms. Not substantial changes in the diagnosis of OA emerged, but new potential frameworks for better management and health surveillance of OA arose. Conclusions Exposure to respiratory hazards at work is still an important cause of asthma worldwide and in the UK, with important costs for both the individual and the society. Updated evidence-based guidelines on the prevention and management of OA are key to guide healthcare workers' decisionmaking in their routine clinical practice.
